Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Deserves More Respect
TheStreet.com
Fri, 02/14/14 - 10:50 am
Tags:
AbbVie
Big Pharma Diversification: A Winning Model or Recipe for Disaster?
Motley Fool
Tue, 02/11/14 - 12:03 pm
Tags:
Big Pharma, diversification, Merck, Eli Lilly, AbbVie, Abbott Laboratories, Pfizer
Why AbbVie's First Year on Its Own Was a Success
Motley Fool
Mon, 02/10/14 - 12:04 pm
Tags:
AbbVie
The Hep C Race Is Heating Up: AbbVie Vs. Gilead
Seeking Alpha
Mon, 02/10/14 - 08:35 am
Tags:
AbbVie, Gilead Sciences, hepatitis C, Sovaldi
AbbVie is hit with 5 lawsuits citing the dangers of its 'low T' drug
Fierce Pharma
Fri, 02/7/14 - 10:52 am
Tags:
AbbVie, Androgel, FDA
AbbVie Expands Manufacturing Presence with US$320 Million Investment in Singapore
Yahoo
Thu, 02/6/14 - 07:50 am
Tags:
AbbVie, Singapore, drug manufacturing
AbbVie Inc. Is Closer to Much-Needed Diversification, but Is It Enough?
Motley Fool
Wed, 02/5/14 - 07:00 pm
Tags:
AbbVie, earnings
Abbott sued on claims of Androgel danger, Bloomberg says
Yahoo/Fly on the Wall
Wed, 02/5/14 - 06:55 pm
Tags:
Androgel, Abbott Laboratories, AbbVie
AbbVie's Challenge to Gilead in Hepatitis C Therapies
Motley Fool
Tue, 02/4/14 - 07:00 pm
Tags:
AbbVie, Gilead Sciences, Sovaldi, hepatitis C, Enanta Pharmaceuticals, ABT-450
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
Tags:
AbbVie, Enanta Pharmaceuticals, ABT-450, hepatitis C, Medivation, Xtandi, prostate cancer, Astellas, Geron, imetelstat, PSMA-ADC, Progenics Pharmaceuticals, Idenix
AbbVie Headed to FDA, Clash With Gilead Set
Motley Fool
Sat, 02/1/14 - 10:49 am
Tags:
AbbVie, Gilead Sciences, ABT-450, hepatitis, hepatitis C, Enanta Pharmaceuticals
AbbVie 4th-quarter earnings slide, hit by generics competition
Yahoo/Reuters
Fri, 01/31/14 - 08:13 am
Tags:
earnings, AbbVie
Is AbbVie (ABBV) Poised to Beat Earnings Estimates?
Yahoo/Zacks.com
Thu, 01/30/14 - 02:51 pm
Tags:
earnings, AbbVie
AbbVie Advances with Cancer Candidate
Yahoo/Zacks.com
Thu, 01/16/14 - 09:31 am
Tags:
AbbVie, veliparib, triple-negative breast cancer
Enanta Joins Big Leagues With Hepatitis C Drug
Investors.com
Wed, 01/8/14 - 08:07 am
Tags:
Enanta, hepatitis C, AbbVie, ABT-450, protease inhibitors
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Tags:
Bristol-Myers Squibb, Celgene, Gilead Sciences, Biogen Idec, AbbVie, Roche, JNJ, GSK, Amgen, Novo Nordisk, Pfizer, Novartis, Merck, Sanofi, AstraZeneca, Eli Lilly
This Week in Biotech
Motley Fool
Sun, 12/22/13 - 12:28 pm
Tags:
GSK, Theravance, Ariad Pharmaceuticals, Gilead Sciences, AbbVie, Cubist Pharmaceuticals, Jazz Pharmaceuticals, Gentium
Why Enanta Pharmaceuticals Shares Sank Like a Stone
Motley Fool
Thu, 12/19/13 - 08:08 am
Tags:
Enanta, Sovaldi, Gilead Sciences, hepatitis C, ABT-450, AbbVie
Sandoz starts late-stage trial with copy of AbbVie's Humira drug
Yahoo/AP
Wed, 12/18/13 - 05:14 pm
Tags:
Sandoz, generics, Humira, AbbVie, biosimilars, Novartis
Keep an Eye on Biogen, Johnson & Johnson, and Merck Today
Motley Fool
Tue, 12/17/13 - 10:42 am
Tags:
Biogen Idec, JNJ, Merck, Bravecto, animal health, Samsung, Hospira, Amgen, AbbVie, anti-TNF

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.